HopeStage
Back to all studies
CompletedNCT06215261

Methylone safety study for post-traumatic stress

About this titleRead the official source — NCT06215261

Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.

Medication studyAges 18–70Multiple countries
The study in practice

Understand this study

What did researchers investigate?

Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.

Who was this study for?

This study was for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Listed locations
Lauderhill and 11 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 4, 2024
Recruitment status
Completed
Enrollment listed in the registry
62
Sponsor
Transcend Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Australia, United Kingdom
Age range
From 18 Years to 70 Years
Official registry ID
NCT06215261
Official title
Show the full official title

An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD IMPACT-2 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Lauderhill, United States · Maitland, United States · Orlando, United States

8 more locations
  • Chicago, United States
  • Rockville, United States
  • Las Vegas, United States
  • Draper, United States
  • Bellevue, United States
  • Hawthorn, Australia
  • Melbourne, Australia
  • London, United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.

Who is behind this study?

The study sponsor is Transcend Therapeutics.

Did this study involve medication?

Yes. The study involved medication, including Methylone.

Who was this study for?

This study was for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies